Chronic Hepatitis B is a long-lasting liver infection caused by the Hepatitis B virus. It can be passed from mother to baby, through blood, or during sex. If not treated, it can cause serious liver scarring and damage over many years.
Every report comes from a Lived member, sent anonymously.
Have you tried Tenofovir for Chronic Hepatitis B?
Chronic hepatitis B is a long-lasting infection of the liver with the hepatitis B virus. Doctors call the infection chronic when the virus is still present in the blood six months or more after it began. The virus itself does little direct harm to liver cells. The damage comes mainly from the immune system's ongoing attempts to clear it, which can keep the liver inflamed for years. Most people with chronic hepatitis B feel well and have no symptoms, often for decades. What matters is what can develop quietly in that time: cirrhosis (scarring that stops the liver from working normally), liver failure and liver cancer. Many people never develop these complications, and the risk varies a great deal from person to person. That is why regular check-ups matter even when nothing feels wrong, and why an estimated two thirds of people living with hepatitis B in the United States may not know they have it.
The hepatitis B virus spreads through blood, semen and other body fluids. It can pass from a mother to her baby at birth, through sex, through shared needles or other drug-injection equipment, through needlestick injuries or unsterile tattoo and piercing tools, and through shared razors, toothbrushes or nail clippers. It does not spread through coughing, sneezing, hugging, holding hands, or sharing food, drinks or utensils. Whether an infection becomes chronic depends mostly on age at the time of infection. About 90% of infants infected in their first year develop chronic hepatitis B, compared with 25% to 50% of children infected between ages 1 and 5 and about 5% of adults. A weakened immune system, such as from HIV, also raises the chance. This is why, in the United States, chronic hepatitis B is most common among people born in parts of Asia, Africa, the Middle East, Eastern Europe and South America where the virus is widespread, and among children of parents from those regions who were not vaccinated as infants. For someone already living with the virus, other factors raise the chance of serious liver damage: alcohol, fatty liver disease, infection with hepatitis C, hepatitis D or HIV, older age, and a family history of liver cancer.
Hepatitis B is diagnosed with blood tests, and because most people have no symptoms, it is usually found through screening. In the United States, the Centers for Disease Control and Prevention (CDC) recommends testing every adult at least once and every pregnant person in each pregnancy. The standard screening panel has three tests. Hepatitis B surface antigen (HBsAg) is a piece of the virus and shows a current infection. Surface antibody (anti-HBs) shows protection, from vaccination or a past infection that cleared. Core antibody (anti-HBc) shows that the person has been infected at some point. An HBsAg result that stays positive for at least six months means the infection is chronic. Once chronic infection is confirmed, further tests show how active it is. The HBV DNA test, or viral load, measures how much of the virus's genetic material is in the blood, reported in international units per milliliter (IU/mL). ALT is a liver enzyme that rises when liver cells are inflamed; liver specialists generally treat an ALT above about 35 U/L in men or 25 U/L in women as raised when managing hepatitis B. A test for the hepatitis B e antigen (HBeAg) helps place the infection in its current phase. These values change over time, so a pattern across several visits tells more than a single result. To check for scarring, doctors use elastography (such as FibroScan), a quick ultrasound-based scan that measures liver stiffness, or blood-based fibrosis scores. A liver biopsy is reserved for cases where these do not give a clear answer. The first evaluation usually also includes tests for hepatitis C, hepatitis D and HIV, and checks whether the person is protected against hepatitis A.
Not everyone with chronic hepatitis B needs medicine right away. Treatment is generally recommended when tests show the virus is actively inflaming the liver (typically a high viral load with a raised ALT), when there is significant scarring or cirrhosis, and in certain other situations such as late pregnancy with a high viral load or before chemotherapy. People who don't need treatment yet still have regular blood tests, because the infection can become more active later. The main treatments are antiviral tablets taken once a day: entecavir (Baraclude), tenofovir disoproxil fumarate (Viread) and tenofovir alafenamide (Vemlidy). They keep the virus at very low or undetectable levels, which calms liver inflammation and lowers the risk of cirrhosis, liver failure and liver cancer over time. The virus rarely becomes resistant to them, and side effects are uncommon. Tenofovir alafenamide or entecavir may be chosen for people with kidney or bone problems. People are tested for HIV before starting, because using one of these medicines alone in someone with untreated HIV can make HIV resistant to treatment. These medicines control the virus but seldom clear it, so most people take them for many years, often for life. Stopping can set off a severe flare of hepatitis, which is a boxed warning on all three. Any decision to stop is made with the prescriber and followed by close blood testing for months. Peginterferon alfa is a different approach: a weekly injection, usually for 48 weeks, that strengthens the immune response against the virus. It appeals to some people because treatment has a set end date, but it is not suitable for people with advanced cirrhosis, autoimmune disease, uncontrolled psychiatric illness, severe heart disease, uncontrolled seizures or low blood counts. During pregnancy, tenofovir disoproxil fumarate is suggested in the third trimester when the viral load is above 200,000 IU/mL, to lower the chance of passing the virus to the baby. Every baby born to a mother with hepatitis B should receive the hepatitis B vaccine and hepatitis B immune globulin (HBIG, a dose of protective antibodies) right after birth. For people whose liver fails or who develop liver cancer, a liver transplant may be an option, with antivirals and HBIG used to protect the new liver.
Chronic hepatitis B tends to shift between phases over the years. At times the virus multiplies heavily with little liver inflammation; at other times the immune system attacks infected cells and the liver becomes inflamed; often the infection settles into a quieter phase with low virus levels, though it can reactivate. Because of this, living with hepatitis B means long-term follow-up with a primary care clinician or liver specialist, including during quiet years. For many people, daily life changes little. When treatment is needed, it is usually one tablet a day and blood tests every few months. Antiviral treatment lowers but does not remove the risk of liver cancer, so people at higher risk are advised to have a liver ultrasound every six months, sometimes with an AFP (alpha-fetoprotein) blood test. This includes anyone with cirrhosis, Asian or African American men over 40, Asian women over 50, people with a close relative who had liver cancer, and people with hepatitis D. Liver cancer found early is more treatable. Protecting the liver also matters: avoiding alcohol, keeping a healthy weight to limit fatty liver, getting vaccinated against hepatitis A, and checking with a clinician before starting new medicines or supplements, some of which can harm the liver. Household members and sex partners should be tested and vaccinated if they are not already protected, and condoms reduce the risk to a partner until their immunity is confirmed. Covering cuts, not sharing razors or toothbrushes, and not donating blood, organs or semen prevent spread to others. Hepatitis B is not a reason to be excluded from work, school or child care, and mothers with hepatitis B can breastfeed once the baby has received the vaccine and HBIG.
Arrange testing if you have never been screened, are pregnant or planning a pregnancy, or live with or have a partner who has hepatitis B. If you have hepatitis B, or had it in the past, tell your prescriber before starting chemotherapy, rituximab or other immune-suppressing drugs, a long course of steroids, or hepatitis C treatment, since these can reactivate the virus and preventive antiviral treatment may be needed. Contact your care team promptly if you have stopped or run out of your antiviral medicine, or if you notice yellowing of the skin or eyes, dark urine, unusual tiredness, itching, weight loss or swelling of the ankles and legs. These can be signs of a flare or of liver damage progressing. If someone else is exposed to your blood, for example through a needlestick, or an unvaccinated partner is exposed through sex, they should see a doctor right away: a vaccine dose, sometimes with HBIG, works best within 24 hours. Get emergency care for vomiting blood, rectal bleeding or black stools, new or worsening confusion or drowsiness, or belly swelling that is new or suddenly worse. These can signal serious complications of advanced liver disease.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Chronic Hepatitis B is like, what's helped you, or ask the community a question.